Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aristoil is a Mediterranean-based organization and cluster focused on the health-protecting properties of olive oil, specifically those rich in phenolic compounds. Originating from an EU-funded Interreg MED project, the entity works to identify, certify, and promote high-phenolic olive oils that meet the European Food Safety Authority (EFSA) health claim for protecting blood lipids from oxidative stress. Aristoil collaborates with academic institutions to research the therapeutic potential of specific compounds like oleocanthal and oleacein in areas such as oncology, neurology, and cardiology. The organization provides standardized testing and certification for producers to ensure their products meet medicinal-grade standards for functional food applications. Through its network, Aristoil supports clinical trials investigating the efficacy of high-phenolic oils in treating mild cognitive impairment and other chronic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ARISTOIL.